Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan heart failure with preserved ejection fraction study (I-Preserve) trial

被引：0
|
作者：
Zile, M. R. [1 ,2 ]
Gaasch, W. H. [3 ]
Anand, I. [4 ,5 ]
Haass, M. [6 ]
Little, W. C. [7 ]
Miller, A. [8 ]
Lopez-Sendon, J. [9 ]
Teerlink, J. R. [10 ,11 ]
White, M. [12 ]
Carson, P. E. [13 ,14 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] VA Med Ctr, Charleston, SC USA
[3] Lahey Clin Fdn, Burlington, MA USA
[4] Univ Minnesota, Minneapolis, MN USA
[5] VA Med Ctr, Minneapolis, MN USA
[6] Theresienkrankenhaus, Mannheim, Germany
[7] Wake Forest Med Ctr, Winston Salem, NC USA
[8] Univ Florida Shands Jacksonville, Jacksonville, FL USA
[9] Hosp Gen Gregorio Maranon, Madrid, Spain
[10] Univ Calif San Francisco, San Francisco, CA 94143 USA
[11] VA Med Ctr, San Francisco, CA USA
[12] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[13] Georgetown Univ, Washington, DC USA
[14] VA Med Ctr, Washington, DC USA
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：867 / 867
页数：1
相关论文
共 50 条
  • [1] Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
    Zile, Michael R.
    Gaasch, William H.
    Anand, Inder S.
    Haass, Markus
    Little, William C.
    Miller, Alan B.
    Lopez-Sendon, Jose
    Teerlink, John R.
    White, Michel
    McMurray, John J.
    Komajda, Michel
    McKelvie, Robert
    Ptaszynska, Agata
    Hetzel, Scott J.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION, 2010, 121 (12) : 1393 - 1405
  • [2] Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE)
    Carson, P. E.
    Komajda, M.
    Zile, M. R.
    Mckelvie, R.
    Mcmurray, J. J.
    Hetzel, S.
    Demets, D.
    Staiger, C.
    Ptaszynska, A.
    Massie, B. M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 865 - 865
  • [3] Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE)
    Komajda, Michel
    Carson, Peter E.
    Hetzel, Scott
    McKelvie, Robert
    McMurray, John
    Ptaszynska, Agata
    Zile, Michael R.
    DeMets, David
    Massie, Barry M.
    CIRCULATION-HEART FAILURE, 2011, 4 (01) : 27 - U73
  • [4] Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Haass, Markus
    Kitzman, Dalane W.
    Anand, Inder S.
    Miller, Alan
    Zile, Michael R.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION-HEART FAILURE, 2011, 4 (03) : 324 - 331
  • [5] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Lam, Carolyn S. P.
    Carson, Peter E.
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Massie, Barry M.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
  • [6] The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE)
    Carson, Peter
    Komajda, Michel
    Zile, Michael
    Johnson, Ralph H.
    Hetzel, Scott
    Mckelvie, Robert
    McMurray, John
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    CIRCULATION, 2009, 120 (18) : S749 - S749
  • [7] The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
    Carson, Peter E.
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas
    Haass, Markus
    Lopez-Sendon, Jose
    Miller, Alan
    Teerlink, John R.
    White, Michel
    McKelvie, Robert S.
    Komajda, Michel
    Zile, Michael R.
    McMurray, John J.
    Massie, Barry
    JACC-HEART FAILURE, 2015, 3 (06) : 429 - 441
  • [8] Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
    Kristensen, Soren L.
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Preiss, David
    Win, Sithu
    Kober, Lars
    McKelvie, Robert S.
    Zile, Michael R.
    Anand, Inder S.
    Komajda, Michel
    Gottdiener, John S.
    Carson, Peter E.
    McMurray, John J. V.
    CIRCULATION, 2017, 135 (08) : 724 - +
  • [9] MORBIDITY AND MORTALITY IN DIABETICS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION: RESULTS FROM THE I-PRESERVE TRIAL
    Win, Sithu
    Anand, Inderjit
    McMurray, John
    Zile, Michael
    McKelvie, Robert
    Komajda, Michel
    Massie, Barry
    Carson, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E706 - E706
  • [10] Predictors of outcome in heart failure with preserved ejection fraction: One year findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE)
    Carson, Peter E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A251 - A251
12345